Track the 케이엠제약 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Banks sector, 케이엠제약 has recorded 56 reports. Market capitalisation: €9.7bn. The latest transaction was disclosed on 8 July 2026 (Purchase). Among the most active insiders: 강일모. Every trade is free.
50
Insider Decl.
n/a
Thresholds
€109,057
36 ops.
Buy Volume
n/a
1 ops.
Sell Volume
30Σ signal
Buys €109,057n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,176 of 29,064 companies
12.5
score / 100
Value
6
Quality
19
FCF yld-27%
Earn yld-53%
EV/EBITDA·
ROE-13%
Gross mgn24%
Net mgn-25%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.